Robertm Plenge News Today

Atria Investments Inc increased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 160,279 shares of the biopharmaceutical company’s stock after acquiring an additional 7,402 shares during the period. Atria Investments Inc’s holdings […]

American International Group Inc. boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.4% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 562,489 shares of the biopharmaceutical company’s stock after purchasing an additional 2,160 shares during the period. American International Group Inc.’s holdings in Bristol-Myers […]

Sandy Spring Bank cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 119,472 shares of the biopharmaceutical company’s stock after selling 2,350 shares during the period. Sandy Spring Bank’s […]

B&D White Capital Company LLC bought a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 98,375 shares of the biopharmaceutical company’s stock, valued at approximately $6,291,000. Bristol-Myers Squibb comprises […]

New York Life Investment Management LLC cut its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 339,166 shares of the biopharmaceutical company’s stock after selling 2,358 shares during the […]

Carnegie Capital Asset Management LLC reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 18.3% in the second quarter, Holdings Channel reports. The firm owned 97,849 shares of the biopharmaceutical company’s stock after selling 21,956 shares during the period. Carnegie Capital Asset Management LLC’s holdings in Bristol-Myers Squibb were worth $6,257,000 […]

Towercrest Capital Management grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 24.0% in the 2nd quarter, HoldingsChannel reports. The firm owned 5,341 shares of the biopharmaceutical company’s stock after acquiring an additional 1,034 shares during the quarter. Towercrest Capital Management’s holdings in Bristol-Myers Squibb were worth $342,000 as of its […]

Atria Investments Inc boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the 2nd quarter, Holdings Channel reports. The fund owned 160,279 shares of the biopharmaceutical company’s stock after acquiring an additional 7,402 shares during the quarter. Atria Investments Inc’s holdings in Bristol-Myers Squibb were worth $10,246,000 at the […]

BMO Capital Markets cut shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from an outperform rating to a market perform rating in a report released on Friday morning, MarketBeat.com reports. The firm currently has $60.00 price target on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on BMY. SVB Leerink […]

BMO Capital Markets cut shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) from an outperform rating to a market perform rating in a research note released on Friday morning, MarketBeat Ratings reports. They currently have $60.00 price target on the biopharmaceutical company’s stock. Other equities analysts have also issued reports about the company. William Blair […]